Top Markets
Coin of the day
Lobe Sciences Ltd. Lobe Sciences Ltd.

Lobe Sciences Ltd.

LOBE
Rank in Stocks #30765
Lobe Sciences Ltd. operates as a life sciences entity, primarily focused on the... Lobe Sciences Ltd. operates as a life sciences entity, primarily focused on the exploration and advancement of psychedelic pharmaceutical compounds. The company is actively engaged in formulating psilocybin-derived therapeutics, combined with N-acetylcysteine, intended for the treatment of mild traumatic brain injuries and post-traumatic stress disorder. Beyond drug development, it also engineers specialized devices designed to facilitate the efficient delivery of various medications. The organization was previously known as Greenstar Biosciences Corp. before formally changing its name to Lobe Sciences Ltd. in November 2020. Its main corporate office is situated in Vancouver, Canada.
Share Price
$0.05504527
Last synced: 2026-08-17
Market Cap
$15.64M
Change (1 day)
0.00%
Change (1 year)
51.92%
Country
CA
Trade Lobe Sciences Ltd. (LOBE)

Category

EPS for Lobe Sciences Ltd. (LOBE)
EPS as of 2026 TTM: 0
According to Lobe Sciences Ltd. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Lobe Sciences Ltd. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors